GRANULES INDIA
Back to Balance Sheet
|
GRANULES INDIA Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹2,003 Cr | ₹2,082 Cr | ₹1,814 Cr | ₹1,642 Cr | ₹1,173 Cr |
What is the latest Total Current Liabilities ratio of GRANULES INDIA ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹2,003 Cr |
| Mar2024 | ₹2,082 Cr |
| Mar2023 | ₹1,814 Cr |
| Mar2022 | ₹1,642 Cr |
| Mar2021 | ₹1,173 Cr |
How is Total Current Liabilities of GRANULES INDIA Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,003 Cr | -3.80 | |
| Mar2024 | ₹2,082 Cr | 14.82 | |
| Mar2023 | ₹1,814 Cr | 10.47 | |
| Mar2022 | ₹1,642 Cr | 39.94 | |
| Mar2021 | ₹1,173 Cr | - | |
Compare Total Current Liabilities of peers of GRANULES INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GRANULES INDIA | ₹14,115.4 Cr | -3.4% | 1.4% | 5.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -3.5% | -6.4% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,492.0 Cr | -5.8% | -1.6% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,013.0 Cr | 1.4% | 7% | 23.7% | Stock Analytics | |
| CIPLA | ₹112,922.0 Cr | -4.7% | -6.8% | -0.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,115.0 Cr | -2.8% | -8.1% | -11.1% | Stock Analytics | |
GRANULES INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GRANULES INDIA | -3.4% |
1.4% |
5.6% |
| SENSEX | -0.7% |
-1.9% |
8% |
You may also like the below Video Courses